857 related articles for article (PubMed ID: 16333884)
1. The pharmacological approach to reverse portal hypertention and hepatic schistosomal fibrosis in Egypt, control experimental study.
Helmy AH; Abdel-Hady AA; el-Shanawany F; Hammam O; Abdel-Hady A
J Egypt Soc Parasitol; 2005 Dec; 35(3):731-50. PubMed ID: 16333884
[TBL] [Abstract][Full Text] [Related]
2. Potential antifibrotic effects of AT1 receptor antagonist, losartan, and/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni.
El-Lakkany NM; El-Maadawy W; Ain-Shoka A; Badawy A; Hammam O; Ebeid F
Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):695-704. PubMed ID: 21762203
[TBL] [Abstract][Full Text] [Related]
3. Impact of treatment with a Protein Tyrosine Kinase Inhibitor (Genistein) on acute and chronic experimental Schistosoma mansoni infection.
Sobhy MMK; Mahmoud SS; El-Sayed SH; Rizk EMA; Raafat A; Negm MSI
Exp Parasitol; 2018 Feb; 185():115-123. PubMed ID: 29331278
[TBL] [Abstract][Full Text] [Related]
4. Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis.
Cheever AW; Williams ME; Wynn TA; Finkelman FD; Seder RA; Cox TM; Hieny S; Caspar P; Sher A
J Immunol; 1994 Jul; 153(2):753-9. PubMed ID: 8021510
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis.
El-Lakkany NM; Hammam OA; El-Maadawy WH; Badawy AA; Ain-Shoka AA; Ebeid FA
Parasit Vectors; 2012 Jan; 5():9. PubMed ID: 22236605
[TBL] [Abstract][Full Text] [Related]
6. Intrasplenic transplantation of IL-18 gene-modified hepatocytes: an effective approach to reverse hepatic fibrosis in schistosomiasis through induction of dominant Th1 response.
Zhang LH; Pan JP; Yao HP; Sun WJ; Xia DJ; Wang QQ; He L; Wang J; Cao X
Gene Ther; 2001 Sep; 8(17):1333-42. PubMed ID: 11571570
[TBL] [Abstract][Full Text] [Related]
7. The therapeutic effect of the neuropeptide hormone somatostatin on Schistosoma mansoni caused liver fibrosis.
Chatterjee S; Vrolix G; Depoortere I; Peeters T; Van Marck E
BMC Infect Dis; 2005 Jun; 5():45. PubMed ID: 15949036
[TBL] [Abstract][Full Text] [Related]
8. Sodium valproate, a histone deacetylase inhibitor, with praziquantel ameliorates Schistosoma mansoni-induced liver fibrosis in mice.
Elsakkar MG; Eissa MM; Hewedy WA; Nassra RM; Elatrebi SF
Life Sci; 2016 Oct; 162():95-101. PubMed ID: 27528511
[TBL] [Abstract][Full Text] [Related]
9. Artichoke leaf extract protects liver of Schistosoma mansoni infected mice through modulation of hepatic stellate cells recruitment.
Sharaf El-Deen SA; Brakat RM; Mohamed ASED
Exp Parasitol; 2017 Jul; 178():51-59. PubMed ID: 28552793
[TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic and anti-proliferative activity of ziziphus leaf extract as a novel potential therapeutic agent for reducing hepatic injury in experimental hamster schistosomiasis.
Alghamdi T; Salem DA; El-Refaei MF
PLoS Negl Trop Dis; 2023 Jun; 17(6):e0011426. PubMed ID: 37339146
[TBL] [Abstract][Full Text] [Related]
11. Parasitological and histo-pathological studies on schistosomiasis mansoni infected mice and treated with praziquatel and/or oltipraz.
Morsy GH
J Egypt Soc Parasitol; 2009 Aug; 39(2):687-701. PubMed ID: 19795775
[TBL] [Abstract][Full Text] [Related]
12. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response.
Chiaramonte MG; Donaldson DD; Cheever AW; Wynn TA
J Clin Invest; 1999 Sep; 104(6):777-85. PubMed ID: 10491413
[TBL] [Abstract][Full Text] [Related]
13. Effect of adamantylamide dipeptide as adjuvant therapy to praziquantel in mice infected with different S. mansoni isolates.
Botros S; Mahmoud M; Hammam O; Salah F; Zidek Z; Masek K
APMIS; 2006; 114(7-8):480-91. PubMed ID: 16907853
[TBL] [Abstract][Full Text] [Related]
14. Parasitological, hematological and ultrastructural study of the effect of COX-2 inhibitor, pyocyanin pigment and praziquantel, on S. mansoni infected mice.
Mohamed AH; Ezz El-Din N; Fahmy ZH; El-Shennawy AM; Hassan E
J Egypt Soc Parasitol; 2006 Apr; 36(1):197-220. PubMed ID: 16605111
[TBL] [Abstract][Full Text] [Related]
15. Effect of interferon-alpha on experimental Schistosoma mansoni infection in mice.
Abd El-Aal AA; El-Arousy MH; Issa R; Hassan IH; Rashed L; Ismail S; Mahmoud AH
J Egypt Soc Parasitol; 2005 Aug; 35(2):403-20. PubMed ID: 16083055
[TBL] [Abstract][Full Text] [Related]
16. Systemic delivery of an adenovirus expressing EBV-derived vIL-10 in mice infected with Schistosoma mansoni or Leishmania amazonensis: controversial effects on the development of pathological parameters.
Verwaerde C; Thiam K; Delanoye A; Fernandez-Gomez R; D'Halluin J; Auriault C
Eur Cytokine Netw; 1999 Jun; 10(2):161-70. PubMed ID: 10400822
[TBL] [Abstract][Full Text] [Related]
17. Lack of antigen-specific Th1 response alters granuloma formation and composition in Schistosoma mansoni-infected MyD88-/- mice.
Layland LE; Wagner H; da Costa CU
Eur J Immunol; 2005 Nov; 35(11):3248-57. PubMed ID: 16276483
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of an antipathology vaccine in murine schistosomiasis administered with and without chemotherapy.
Botros SS; Doughty BL; Shaker ZA; Akl MM; Sharmy R; Diab TM; Hassanein HI
Int J Immunopharmacol; 1996 Dec; 18(12):707-18. PubMed ID: 9172014
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics of pentoxifylline and/or praziquantel in murine schistosomiasis mansoni.
El-Lakkany N; Nosseir M
APMIS; 2007 Mar; 115(3):184-94. PubMed ID: 17367463
[TBL] [Abstract][Full Text] [Related]
20. Paeoniflorin targets apoptosis and ameliorates fibrosis in murine schistosomiasis mansoni: A novel insight.
Abd El-Aal NF; Hamza RS; Harb O
Exp Parasitol; 2017 Dec; 183():23-32. PubMed ID: 29037782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
